507 related articles for article (PubMed ID: 12588808)
21. A Carboxy-Terminal Monoleucine-Based Motif Participates in the Basolateral Targeting of the Na+/I- Symporter.
Martín M; Modenutti CP; Peyret V; Geysels RC; Darrouzet E; Pourcher T; Masini-Repiso AM; Martí MA; Carrasco N; Nicola JP
Endocrinology; 2019 Jan; 160(1):156-168. PubMed ID: 30496374
[TBL] [Abstract][Full Text] [Related]
22. Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.
Bizhanova A; Kopp P
Endocrinology; 2009 Mar; 150(3):1084-90. PubMed ID: 19196800
[TBL] [Abstract][Full Text] [Related]
23. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
Carvalho DP; Ferreira AC
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
[TBL] [Abstract][Full Text] [Related]
24. The Na/I symporter (NIS): imaging and therapeutic applications.
Dadachova E; Carrasco N
Semin Nucl Med; 2004 Jan; 34(1):23-31. PubMed ID: 14735456
[TBL] [Abstract][Full Text] [Related]
25. Extending the clinical heterogeneity of iodide transport defect (ITD): a novel mutation R124H of the sodium/iodide symporter gene and review of genotype-phenotype correlations in ITD.
Szinnai G; Kosugi S; Derrien C; Lucidarme N; David V; Czernichow P; Polak M
J Clin Endocrinol Metab; 2006 Apr; 91(4):1199-204. PubMed ID: 16418213
[TBL] [Abstract][Full Text] [Related]
26. Sodium/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide.
Josefsson M; Grunditz T; Ohlsson T; Ekblad E
Acta Physiol Scand; 2002 Jun; 175(2):129-37. PubMed ID: 12028133
[TBL] [Abstract][Full Text] [Related]
27. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
28. The Na+/I- symporter (NIS): recent advances.
Levy O; De la Vieja A; Carrasco N
J Bioenerg Biomembr; 1998 Apr; 30(2):195-206. PubMed ID: 9672241
[TBL] [Abstract][Full Text] [Related]
29. Signaling through 3',5'-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer.
Knostman KA; Cho JY; Ryu KY; Lin X; McCubrey JA; Hla T; Liu CH; Di Carlo E; Keri R; Zhang M; Hwang DY; Kisseberth WC; Capen CC; Jhiang SM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5196-203. PubMed ID: 15472226
[TBL] [Abstract][Full Text] [Related]
30. PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer.
Knostman KA; McCubrey JA; Morrison CD; Zhang Z; Capen CC; Jhiang SM
BMC Cancer; 2007 Jul; 7():137. PubMed ID: 17651485
[TBL] [Abstract][Full Text] [Related]
31. The Iodide Transport Defect-Causing Y348D Mutation in the Na
Reyna-Neyra A; Jung L; Chakrabarti M; Suárez MX; Amzel LM; Carrasco N
Thyroid; 2021 Aug; 31(8):1272-1281. PubMed ID: 33779310
[No Abstract] [Full Text] [Related]
32. The sodium/iodide symporter: state of the art of its molecular characterization.
Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
[TBL] [Abstract][Full Text] [Related]
33. Journey of the iodide transporter NIS: from its molecular identification to its clinical role in cancer.
Riedel C; Dohán O; De la Vieja A; Ginter CS; Carrasco N
Trends Biochem Sci; 2001 Aug; 26(8):490-6. PubMed ID: 11504625
[TBL] [Abstract][Full Text] [Related]
34. A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy.
Cho JY
Curr Gene Ther; 2002 Dec; 2(4):393-402. PubMed ID: 12477251
[TBL] [Abstract][Full Text] [Related]
35. Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein.
Tonacchera M; Agretti P; de Marco G; Elisei R; Perri A; Ambrogini E; De Servi M; Ceccarelli C; Viacava P; Refetoff S; Panunzi C; Bitti ML; Vitti P; Chiovato L; Pinchera A
Clin Endocrinol (Oxf); 2003 Oct; 59(4):500-6. PubMed ID: 14510914
[TBL] [Abstract][Full Text] [Related]
36. Dietary I(-) absorption: expression and regulation of the Na(+)/I(-) symporter in the intestine.
Nicola JP; Carrasco N; Masini-Repiso AM
Vitam Horm; 2015; 98():1-31. PubMed ID: 25817864
[TBL] [Abstract][Full Text] [Related]
37. The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.
Paroder V; Nicola JP; Ginter CS; Carrasco N
J Cell Sci; 2013 Aug; 126(Pt 15):3305-13. PubMed ID: 23690546
[TBL] [Abstract][Full Text] [Related]
38. The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues.
Riesco-Eizaguirre G; Santisteban P; De la Vieja A
Endocr Relat Cancer; 2021 Sep; 28(10):T141-T165. PubMed ID: 34387194
[TBL] [Abstract][Full Text] [Related]
39. Expression of the Na+/I- symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus.
Altorjay A; Dohán O; Szilágyi A; Paroder M; Wapnir IL; Carrasco N
BMC Cancer; 2007 Jan; 7():5. PubMed ID: 17214887
[TBL] [Abstract][Full Text] [Related]
40. Sodium-iodide symporter mediates iodide secretion in rat gastric mucosa in vitro.
Josefsson M; Evilevitch L; Weström B; Grunditz T; Ekblad E
Exp Biol Med (Maywood); 2006 Mar; 231(3):277-81. PubMed ID: 16514173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
